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ABSTRACT 
JAMES MITCHUM: Calmodulin/Ca2+-Dependent Protein Kinase II Activity and 
Expression in the Aged Mouse Hippocampus 
(Under the direction of Nicole Ashpole) 
 
 
 
CaM Kinase II (Ca2+/calmodulin-dependent protein kinase II) is a 
serine/threonine-specific protein kinase enzyme that acts as a critical regulator of learning 
and memory. It has previously been shown that the inability of CaMKII to maintain 
activation is connected to memory deficits within the aging brain. While the connection 
between CaMKII dysfunction and learning and memory impairments is well established, 
little is known about the changes that cause CaMKII dysfunction. Our research set out to 
investigate if CaMKII is altered during the process of aging.  Specifically, we looked at 
activity, regulation, and stability by conducting experiments to quantify CaMKII levels of 
activity and protein expression in both young and aged mouse hippocampi. We 
hypothesized that when compared to young mouse hippocampi, aged mouse hippocampi 
would have lower levels of total CaMKII activity, lower levels of phosphorylated 
CaMKII expression, and increased levels of CaMKII inhibitor expression. The impact of 
our research lies in the illumination of the mechanisms causing CaMKII dysfunction. By 
casting light on the process of CaMKII dysfunction, we will help future researchers to 
establish a possible therapeutic target in the fight against learning and memory 
impairments.
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BACKGROUND 
 
 
Ca2+ Signaling in the Brain 
The calcium cation Ca2+ is among the most important secondary messengers in 
cellular signaling, influencing almost every process within the cell. Ca2+ signaling is of 
particular importance in both neuronal growth and survival. Although Ca2+ is vital to the 
livelihood of the cell, it also has the ability to do great cellular harm. Because of the fact 
that the cation is highly reactive and prolonged exposure to high levels of Ca2+ can be 
toxic to the cell. When intracellular Ca2+ levels become too high, both mitochondrial 
depolarization and over-activation of downstream signaling pathways can occur. In order 
to avoid the toxic side effects of high levels of Ca2+ the cell must use pumps, channels, 
and proteins to preserve low cellular concentrations of the cation. A family of proteins 
that play an important role in Ca2+ mediation is the calmodulin (CaM) kinase proteins. 
 
The CaM Kinase Family and the Structure of CaMKII 
The CaM kinases are a group of serine/threonine protein kinases, which are activated 
by calcium-bound calmodulin and phosphorylate a serine or a threonine residue in its 
substrate P-site. The substrate P-site is the target site of phosphorylation. While the CaM 
kinases all share this defining targeting motif, they each undergo different mechanisms of 
regulation. Because of the variation in regulation across the family, CaM kinases play 
roles in a plethora of cellular functions. In this study, we will focus on the neuronal 
functions of CaMKII. Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) is a 
mediator of Ca2+ signaling that has the ability to phosphorylate a variety of substrates in 
order to coordinate and regulate cellular functions related to Ca2+ signaling (Ashpole 
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2011). The mediation functionality of CaMKII arises from the enzyme’s unique structure. 
CaMKII has the form of a multimeric holoenzyme with a C-terminal association domain 
creating a central hub and N-terminal kinase domains protruding outward. In the space 
between these two domains, CaMKII has a Ca2+/CaM-binding autoregulatory region as 
well as a variable region in which splicing can occur (Coultrap 2011). Because of 
CaMKII’s multimeric structure and autoregulatory domain, it is able to play an active 
role in the location, timing, and sensitivity of its action. CaMKII can: (1) be activated in a 
manner dependent on Ca2+ concentration, (2) achieve independence from its initial 
Ca2+/CaM activators, and (3) function as a molecular switch, which is a function vital to 
certain types of learning and memory (Hudmon and Schulman 2002). The four CaMKII 
isoforms are α, β, γ, and δ. All CaMKII isoforms have a catalytic domain, an 
autoregulatory domain, a variable region, as well as a self-association domain. There are 
binding sites for adenosine triphosphate (ATP) and other substrate proteins inside the 
catalytic domain. Moreover, it is at this domain that a phosphate is transferred from ATP 
onto a Ser or Thr substrate residue (Hudmon and Schulman 2002). When 
phosphorylation occurs at Thr-286, CaMKII is constitutively activated due to the fact that 
the autoregulatory domain is blocked and can no longer bind to the p-site. When this 
circumstance occurs, CaMKII remains activated, even when Ca2+ and calmodulin are 
absent (Yang 1999). The variable and self-associative domains are responsible for the 
sensitivity of CaMKII to Ca2+ and calmodulin. The activation state of the enzyme will be 
dictated by CaMKII’s level of sensitivity. Initially, the CaMKII is in an active state; 
autophosphorylation is not possible at this time due to the lack of Ca2+ or calmodulin, 
which are necessary to facilitate binding to neighboring subunits. As Ca2+ and calmodulin 
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levels increase, autophosphorylation takes place resulting in persistent activation of 
CaMKII for a brief period. The autophosphorylation of CaMKII will be discussed later in 
detail. When dephosphorylation of Thr-286 occurs, CaMKII becomes inactivated. It is 
the features of the variable and self-association domains that determine the identity of the 
different CaMKII isoforms. It is important to note that under ischemic conditions, 
CaMKII forms extra-synaptic clusters by way of the CaMKII holoenzyme self-
aggregation mechanism (Dosemeci 2000; Tao-Cheng 2002; Hudmon 2005; Vest 2009). 
 
Prevalence of CaMKII in Neurons 
While CaMKII is found in the majority of tissues, it has particularly high 
concentration within neurons.  The two splice variants which make up the majority of 
isoforms in neurons are α (50 kDa) and β (60 kDa) (Bayer 1998; Schulman 1978). 
CaMKIIβ functions as a targeting or docking module, and CaMKIIα is crucial to 
neuronal plasticity, spatial memory, and hippocampal long-term potentiation (LTP). The 
γ and δ isoforms are highly expressed in astrocytes and are also expressed throughout the 
body (Tobimatsu and Fujisawa 1989; Takeuchi 2000) 
 
Functionality of α-CaMKII in Neuronal Plasticity and Spatial Memory 
α-CaMKII is expressed exclusively in glutamatergic neurons: glutamatergic neurons 
produce glutamate, which is among the most common excitatory neurotransmitters in the 
central nervous system (Institute of Medicine (US) Forum on Neuroscience and Nervous 
System Disorders 1970). In the hippocampus, CaMKII is not localized in the nucleus. 
Thus, α-CaMKII is not directly involved in gene transcription in the hippocampus (Giese 
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2013). It has been established that α-CaMKII plays a part in hippocampal neuronal 
plasticity; for example, it has been shown that CaMKII inhibition induces neuronal 
apoptosis (Ashpole 2012).  Studies have also shown that α-CaMKII mutations impair 
spatial learning in mice (Silva 1992; Ohno 2006). Moreover, α-CaMKIIThr-286A+/- mutant 
mice exhibit impaired new learning induced by extinction training, while extinction 
related unlearning was unaffected (Kimura 2008).  
 
Functionality of α-CaMKII in Long-Term Potentiation 
Long-term potentiation (LTP) and long-term depression (LTD) are synaptic processes 
that take place over an extended period during the learning process. LTP and LTD work 
in opposition to each other: LTP functions to strengthen synapses, and LTD works to 
decrease synaptic strength. The length of time in which LTP takes place makes it a likely 
mechanism of memory storage. When LTP induction occurs, calcium is able to enter the 
cell. Once Ca2+ enters, CaMKII is activated. Upon activation CaMKII translocates to the 
synapse, where it binds to N–methyl-D-aspartate (NMDA) receptors and brings about 
potentiation via the phosphorylation of glutamate receptor subunits (Lisman 2012). 
NMDA receptors are a type of ionotropic glutamate receptor; the flux of Ca2+ through 
NMDA receptors is believed to be critical in synaptic plasticity. Likewise, When CaMKII 
is inhibited, memory formation is substantially impaired (Giese 2013; Lisman 2002; 
Elgersma 2004; Irvine 2006; Wayman 2008; Lucchesi 2011; Coultrap and Bayer 2012; 
Ashpole 2012). Long-term depression (LTD) works in opposition to LTP in order to 
diminish synaptic signaling for an extended period of time. 
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Autophosphorylation of α-CaMKII 
The role of CaMKII in transducing synaptic activity as a means to cause change in 
synaptic strength and facilitate learning and memory is dependent upon the 
autophosphorylation of Thr-286 (Hudmon and Schulman 2002). Upon 
autophosphorylation at Thr-286, CaMKII becomes autonomous, meaning that it acts 
independently from Ca2+ stimulation. It is the autonomy achieved by autophosphorylated 
CaMKII that allows the kinase to control the induction and maintenance of the synaptic 
plasticity underlying learning and memory (Coultrap 2012).  Likewise, CaMKII 
autonomy is known to be of importance in neuronal plasticity as well (Ashpole, Song, 
Brustovetsky, Engleman, Brustovetsky, Cummins, & Hudmon 2012). It is important to 
note that Thr-286 autophosphorylation has a function in the mediation of LTP induction 
and memory formation rather than LTP maintenance and memory storage as evidenced 
by previous inhibitor studies (Coultrap 2012).  Introduction of an α-CaMKIIT286A-129B6F2 
point mutation, which blocks Thr-286 autophosphorylation, results in severe impairments 
to hippocampus-dependent memory formation: this result suggests that 
autophosphorylation is a process of critical importance (Giese 1998; Need and Giese 
2003; Irvine 2005 and 2011). 
 
Dysfunction of CaMKII and Its Connection to Dementia 
The progressive loss of synaptic elements preceding neuronal death has been 
correlated with the advancement of cognitive decline in humans and rodents alike (Terry 
1991; Moolman 2004). The hippocampal and cortical regions show the most loss of these 
features in patients exhibiting symptoms across the cognitive dementia spectrum (Ghosh 
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2015). While the precise mechanism by which synaptic dysfunction occurs in the aging 
brain remains unclear, it has previously been shown that Aβ oligomers are able to bind to 
synaptic sites and reduce LTP while also promoting LTD (Lambert 1998; Walsh 2002; 
Lacor 2004; Shankar 2008; Li 2009). It is thought that Aβ oligomers may target post 
synaptic elements (Marcello 2008) such as CaMKII among other signaling pathways. 
Building upon this thought, it has been shown that Ca2+ concentration homeostasis is 
dysregulated in Alzheimer’s disease (LaFerla 2002; Bezprozvanny 2008). Furthermore, 
Aβ oligomers can intrude on Ca2+ signaling pathways and impair cognitive function 
(Mattson 1991; Demuro 2010). Because of its important role in post-synaptic LTP 
induction, CaMKII is likely a binding target for Aβ oligomers. It has been shown that 
CaMKII is dysfunctional in Alzheimer’s disease hippocampi (Ghosh 2015). Likewise, it 
has been shown that subcellular localization of α-CaMKII autophosphorylation is altered 
in Alzheimer’s diseased brains (Reese 2011). It has been established that treating 
hippocampal neurons with Aβ oligomers impairs CaMKIIα activation (Wang 2013; 
Townsend 2007). Furthermore, redistribution of phosphorylated Thr-286 in CaMKIIα 
could act as a contributor to cognitive impairment in Alzheimer’s disease.  
 
Unknown Mechanism of CaMKII Dysfunction in the Naturally Aging Brain 
Although it has previously been shown that the inability of CaMKII to maintain 
activation is connected to memory deficits within the diseased brain, very little is known 
about the mechanism of CaMKII dysfunction in the naturally aging brain. In this study, 
our central aim was to determine if CaMKII activity, regulation, and or stability are 
altered during the natural process of aging in the wild type mouse hippocampus. In order 
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to accomplish our aim, experiments were done to quantify activity, gene expression, and 
protein expression in both young and aged wild-type mouse hippocampal supernatant and 
aggregate samples.  
 
METHODS 
 
 
Figure 1: Methodology Flow Chart: first, the hippocampi of young and aged mice were 
isolated. The hippocampal samples were then split evenly into two groups. The first 
group of samples were lysed and centrifuged prior to being utilized in protein 
quantification and western blot analysis. The second group of samples underwent qPCR. 
Activity Assays were also performed 
 
Animals and Hippocampus Isolation 
The animals used in this study were young and aged wild type C57Bl6 mice 
purchased from Jackson Laboratories. The mice were aged in house and given access to 
food and water ad libidum. All procedures were approved by the Institutional Animal 
Care and Use Committee. The young mice were between 3 and 4 months old at the time 
of euthanasia, and the aged mice were 24 months old at the time of euthanasia. It is 
important to note that the aged mice used in this study had previously exhibited impaired 
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learning and memory in behavioral studies. In accordance with our IACUC approved 
standard operating procedures, mice were euthanized by rapid decapitation, and the brain 
and dorsal hippocampus was dissected out. 
 
Sample and Buffer Preparation 
In order to prepare the samples, lysis buffer was made using the following recipe: 
50 mM HEPES buffer (pH 7.4), 4 mM EGTA buffer, 10 mM EDTA buffer, 15 mM 
Na4P2O7-10H2O, 100 mM β-glycerophosphate, 25 mM NaF, and protease inhibitor were 
combined in order to yield lysis buffer. After lysis buffer was added to the tissue samples, 
the pellets were sonicated for 3 sec. Next, 200 μl of RIPA buffer was added to each 
supernatant sample; then the supernatant samples were centrifuged for 30 min at 1200 xg. 
The RIPA buffer was made using the following recipe: 50 mM Tris-Cl (pH 7.4), 150 mM 
NaCl, 1% NP-40, ), 25% Na-Deoxycholate, 1 mM PMSF, 1X Roche complete mini 
protease inhibitor cocktail, and 1X Pierce phosphatase inhibitor cocktail. At this point, 
samples were either used in activity assays or underwent protein quantification followed 
by western blot analysis.  
 
Protein Quantification 
A detergent compatible protein assay (DC protein assay) was performed on both 
resuspended pellet and supernatant samples using the microplate assay protocol from the 
BioRad DC Protein Assay instruction manual. 20 μl of Reagent S was added to 1 ml of 
Reagent A to make Reagent A’. Serial solutions of BSA standard were used to establish a 
BSA concentration curve. 1:10 dilutions of each sample were made. On a clean dry 
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microtiter plate, 5 μl of standards as well as diluted and undiluted samples were added. 25 
μl of Reagent A’ was added to each well. Then 200 μl of reagent B was added into each 
well. The microplate was incubated for 15 min and then absorbance was read at 750 nm. 
In order to prepare the protein samples for gel electrophoresis, the volume of protein 
sample necessary to yield 10 μg of protein was calculated. Then specific amounts of 
ddH2O and 4X LDS buffer were added to each protein sample. The LDS buffer was made 
by adding 20 μl of BME to 1 ml of 4X LDS. The mixed samples were then heated for 5 
min at 95 ⁰C, centrifuged, and cooled. The mixed samples were then loaded on to the gel. 
 
SDS-PAGE Protein Electrophoresis 
 The precast gel cassette was prepared by removing the comb and removing the strip 
of tape at the bottom of the cassette. Next, the gel was placed inside the electrophoresis 
cassette holder, and the well and the front reservoirs were filled with 1X MOPS running 
buffer. At this point two important checks were done: it was confirmed that the lip of the 
gel faced the buffer and it was made sure that there were no leaks from the assembly. 
Also, the wells were rinsed 3 times with 1X MOPS running buffer before the samples 
were loaded. Next, the samples were slowly added into their corresponding wells as was 
the appropriate molecular weight marker. The electrodes were connected and the gel was 
run at 80 V until the dye was fully integrated into the gel, which usually took 20 min. The 
voltage was increased to 120 V and the gel ran until loading dye was in the bottom fifth 
of the gel: this step usually took 90 min. The protein samples were now ready to be 
transferred from gel to nitrocellulose membranes. Having presoaked all necessary 
membranes, pads, and filter paper in ice cold 1X NuPAGE transfer buffer, the sandwich 
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assembly was made. Next the assembly was secured in the transfer electrophoresis 
holder, and the outside system was filled with ice cold NuPAGE transfer buffer. The 
system was run at 30 V for a minimum of 1 hr. Once transfer was completed, the 
membranes were soaked in 5% BSA blocking buffer and were shaken for 1 hr. The 
membranes were rinsed 3 times for 5 min with TBST. Next, the membranes were 
incubated with the primary antibody. The primary antibodies used in this study were 
purchased from Cell Signaling Technology. They were CaMKII-Alpha mouse 
monoclonal antibody, P-CaMKII (T286) rabbit monoclonal antibody, CaMKII Nβ mouse 
monoclonal antibody, and GAPDH rabbit monoclonal antibody. The primary antibody 
dilutions used in this study ranged in volume (7-10 ml per gel) and concentration (1:1000 
– 1:5000). The gels were incubated with the diluted primary antibody and TBST on a 
shaker for 1 to 2 hrs at room temperature or overnight at 4 ⁰C. After having been 
incubated with the primary antibody, the gel was now ready to be incubated with the 
secondary antibody. The secondary antibodies used in this study were purchased from 
Invitrogen and ThermoScience. They were ThermoScience goat anti-mouse IgG (H+L) 
secondary antibody (α-CaMKII, CaMKII Nβ, GAPDH) and Invitrogen Goat antiRabbit 
IgG (H+L) cross absorbed secondary antibody (P-CaMKII), The secondary antibody 
dilutions used in this study ranged in volume (7-10 ml per gel) and concentration 
(1:10000-1:20000). The gels were incubated in darkness with the diluted secondary 
antibody in TBST buffer for 1 hr at room temperature. After 1 hr, the secondary antibody 
was discarded and the membranes were washed quickly 3 times in TBST and then were 
washed 3 times for 5 min in TBST. Each of the secondary antibodies used in our study 
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were fluorescently tagged secondary antibodies. The antibodies were visualized using 
Licor Odyssey scanners in the labs of Dr. Jason Paris and Dr. David Pasco.  
 
CaMKII Activity Assay 
The catalytic activity of CaMKII in lysed hippocampi was evaluated by measuring 
phosphorylation of the CaMKII autoregulatory domain autocamtide-2 (AC2). As 
mentioned previously, neuronal cultures were lysed in lysis buffer containing 50 mM 
HEPES, pH 7.4, 4 mM EGTA, 10 mM EDTA, 15 mM Na4P2O7-10H2O, 100 mM β-
glycerophosphate, 25 mM NaF, 1% Triton X-100, and protease inhibitor mixture, 
sonicated, and incubated with 50 mM HEPES, pH 7.4, 100 mM NaCl, 10 mM MgCl2, 
100 M ATP, 2 mM CaCl2, 5 M CaM, 50 M AC2 (KKALRRQETVDAL), and [γ-
32P]ATP (3 μCi per reaction) for 3 min at 30 °C. The linear range of the reaction 
extended from 30 sec to 4 min. Protein levels were assessed, and activity at 1 min was 
normalized to total protein using DC protein assay kit (Bio-Rad). 
 
Real Time Quantitative Polymerase Chain Reaction 
Polymerase Chain Reaction was utilized in order to amplify gene expression of α-
CaMKII (Mm00437967_m1 Camk2a FAM-MGB / 20X), β-CaMKII (Mm00499266_m1 
Camk2d FAM-MGB / 20X), γ-CaMKII (Mm00618054_m1 Camk2g FAM-MGB / 20X), 
δ-CaMKII (Mm00432284_m1 Camk2b FAM-MGB / 20X), and the housekeeping genes 
Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) (Mm03024075_m1 HPRT 
FAM-MGB / 20X) and GAPDH (Mm99999915_g1 GAPDH FAM-MGB / 20X) in 
young and aged mouse hippocampal tissue samples. The Qiagen RNeasy Mini Kit was 
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used in order to isolate the RNA. And the ThermoFisher High-Capacity RNA to cDNA 
Kit was used to reverse transcribe the cDNA. Primers purchased from LifeTech 
Laboratories were used to amplify the desired segments of cDNA.  Applied BioSystem 
TaqMan dye label for PCR per manufacturer’s recommendation. The amplification was 
analyzed using a BioRad CFX Connect Real-Time PCR Detection System, and the Ct 
values were normalized to gene expression of HPRT using the CT normalization 
method. 
 
Data Analysis 
 Data collected from BioRad DC protein assays was quantitatively analyzed to 
establish a concentration curve using Microsoft Excel. Sigma Plot was utilized to 
formulate each of the graphs used in this research study. At multiple points in the study, 
unpaired t-tests were performed to determine the statistical significance of our collected 
data. When the absence of a discernable numerical pattern was evident in both 
preliminary data and Sigma Plot graphical analysis, the unpaired t-test was not utilized. 
However, the unpaired t-test was utilized in all experiments that were of central 
importance to the evaluation of our hypotheses. In this study, a p-value < 0.05 was 
considered statistically significant. 
 
RESULTS 
 
We first conducted in vitro phosphorylation assays in order to examine total CaMKII 
enzymatic activity in both young and aged mouse hippocampi. These in vitro 
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phosphorylation assays exhibited significantly decreased levels of CaMKII activity in the 
hippocampi of aged mice (Figure 2). Once we found CaMKII activity to be significantly 
diminished in the aged mouse hippocampus, we conducted other experiments in order to 
identify the cause of the enzyme’s diminished activity. These experiments were 
immunoblots and Real-Time PCR. Immunoblotting was performed using various 
antibodies in order to enable us to attain a full picture of CaMKII protein expression in 
both the young and aged mouse hippocampus. The first western blot experiment 
performed used α-CaMKII (50 kDa) and GAPDH (40 kDA) antibodies as a means to 
examine relative α-CaMKII expression. Levels of relative alpha CaMKII expression were 
normalized to a value of one. The relative total CaMKII expression western blot yielded 
no discernable pattern linking total CaMKII protein expression to diminished CaMKII 
activity in the aged mouse hippocampus (Figure 3).  
Like the first western blot, the second western blot also used an α-CaMKII antibody; 
however, the samples used in this blot included both supernatants and pellets in order to 
examine aggregation of total CaMKII. As mentioned previously, CaMKII is known to 
aggregate at the self-association domain under ischemic conditions (Dosemeci 2000; 
Tao-Cheng 2002; Hudmon 2005; Vest 2009). Aggregated CaMKII is unable to reactivate 
when needed (Hudmon 1996). In the laboratory, we can assess aggregation by means of 
differential centrifugation (Hudmon 1996). The α-CaMKII aggregation expression 
western blot yielded no discernable pattern linking total CaMKII aggregation to 
diminished CaMKII activity in the aged mouse hippocampus (Figure 4).  
Next, we sought to examine the expression of the CaMKII inhibitor by way of 
western blot using a CaMKN antibody. Sadly, the experiment did not yield quantifiable 
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results. The gel image obtained from this western blot can be found in the supplemental 
data section (Supplemental Figure 5).  
As stated previously the constitutive activity of CaMKII is thought to play a critical 
role in long-term potentiation. This constitutive activity occurs as a result of 
autophosphorylation of Thr-286, which effectively blocks CaMKII’s autoregulatory 
domain from binding to the p-site. We measured the expression of phosphorylated Thr-
286 CaMKII by means of the Cell Signaling Technology P-CaMKII (T286) rabbit 
monoclonal antibody, which recognizes CaMKII phosphorylated at Thr-286.  
Furthermore, we were able to quantify the relative expression of phosphorylated Thr-286 
CaMKII by normalizing to total expression of α-CaMKII for each supernatant sample. 
Quantification of the relative expression of phospho-CaMKII exhibited that expression of 
phosphorylated Thr-286 CaMKII is significantly diminished in the aged mouse 
hippocampus (Figure 5). From this result, we were able to identify a likely link between 
diminished total CaMKII activity and diminished expression of phosphorylation of 
CaMKII at Thr-286.  
Having examined protein expression of CaMKII, we turned our attention to gene 
expression. Real-Time PCR was used in order to examine gene expression of the 
different CaMKII isoforms (α, β, γ, and δ) in young and aged mice. The results of the 
PCR were normalized to HPRT. The Real-Time PCR conducted in this study yielded no 
discernable pattern linking gene expression to diminished CaMKII activity in the aged 
mouse hippocampus (Figure 6). 
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Figure 2: Total CaMKII Activity: Phosphorylation assays revealed that total CaMKII 
activity is diminished in the aged mouse hippocampus. Enzymatic activity was measured 
using counts per minute per milligram of protein (cpms/mg). The diminished activity of 
CaMKII in the aged mouse hippocampus was shown to be statistically significant (p-
value <  0.05 vs. young mice). Figure 2 provides a graphical quantification of the results 
of the total CaMKII activity assay. 
 
 
 
 
 
 
 
 
Total CaMKII Activity 
* = statistical 
significance 
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Figure 3: Relative Expression of the α-CaMKII Antibody: young and aged wild-type 
mouse supernatant hippocampal protein samples were blotted with an α-CaMKII 
antibody as well as an a GAPDH antibody. Levels of alpha CaMKII (α-CaMKII 
antibody) expression were normalized to levels of GAPDH expression. A) a graphical 
quantification of relative alpha CaMKII expression in young and aged wild-type mouse 
supernatant hippocampal tissue samples. B) a representative images of western blots used 
to quantify alpha-CaMKII expression in young and aged wild-type mouse supernatant 
hippocampal tissue samples. See supplemental data section for a full Western blot images 
(Supplemental Figure 1). 
 
 
 
 
 
A 
 
B 
Expression of Alpha CaMKII Protein 
50 
kDa 
40 
kDa 
α-CaMKII GAPDH 
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Figure 4: Expression of the α-CaMKII Antibody during Aggregation: young and 
aged wild-type mouse pellet and supernatant hippocampal tissue samples were blotted 
with a CaMKIIα antibody in order to quantify expression levels of CaMKIIα aggregation. 
A) a graphical analysis of quantified levels of total CaMKII aggregation expression in 
young and aged wild-type mouse pellet and supernatant hippocampal tissue samples. The 
ratio used in this analysis was soluble to insoluble CaMKII (supernatant to pellet). B) a 
representative image of a western blot gel used to quantify total CaMKII aggregation 
expression. See supplemental data section for a full Western blot image (Supplemental 
Figure 2). 
A 
 
B 
 
Expression of Alpha CaMKII Aggregation 
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Figure 5: Relative Expression of the P-CaMKII Antibody: young and aged wild-type 
mouse supernatant hippocampal tissue samples were blotted with a p-CaMKII antibody 
and an α-CaMKII antibody. Levels of phospho-CaMKII expression (p-CaMKII antibody) 
were normalized to levels of total CaMKII expression (α-CaMKII antibody). A) a 
graphical quantification of relative phospho-CaMKII expression in young and aged wild-
type mouse supernatant hippocampal tissue samples (p-value = 0.03). B) representative 
images of the western blot gel used to quantify relative phospho-CaMKII expression in 
young and aged mouse supernatant samples. See supplemental data section for full 
western blot images (Supplemental Figure 3). 
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Figure 6: Real-Time PCR of the CaMKII Isoforms: mouse hippocampal tissue 
samples underwent real-time qPCR in order to analyze gene expression of the different 
CaMKII isoforms. The major CaMKII isoforms are α, β, γ, and δ. The CT values were 
normalized to gene expression of HPRT using the CT normalization method.  A) a 
graphical analysis of quantified gene expression levels of the CaMKII isoforms (α, β, γ, 
and δ) in young and aged mouse hippocampal tissue samples.  
  
A 
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DISCUSSION 
 
We hypothesized that when compared to young wild-type mouse hippocampi, aged 
wild-type mouse hippocampi would have lower levels of total CaMKII activity, lower 
levels of phosphorylated CaMKII expression, and higher levels of CaMKII inhibitor 
expression. Activity assays, qPCR, protein quantification, and western blots were 
conducted in order to test our hypotheses and to explore alternate explanations. The 
results of the activity assay supported our hypothesis that total CaMKII phosphorylation 
activity levels would be lower in aged mouse hippocampi than in young hippocampi. 
Likewise, the results of our western blot analysis of relative phospho-CaMKII expression 
supported our hypothesis that phospho-CaMKII expression would be diminished in the 
aged wild-type mouse hippocampi. It is worth noting that the results of the relative 
phospho-CaMKII western blot were significant having a p-value of 0.03 (p-value<0.05). 
Our finding that phospho-CaMKII expression is significantly diminished in the aged 
hippocampus suggests that dysfunction within the process of CaMKII phosphorylation at 
Thr-286 contributes to the decline in total CaMKII activity. Furthermore, because of the 
importance of Thr-286 autophosphorylation in the enzyme’s mediation of LTP induction, 
it is plausible that diminished phosphorylation of CaMKII at Thr-286 contributed to the 
learning and memory impairments exhibited by the aged mice in behavioral studies. As 
was mentioned earlier, we were unsuccessful in our attempt to quantify expression of the 
CaMKII inhibitor; it is unclear as to whether this result was due to human error or a 
faulty antibody. The results of the qPCR did not exhibit that changes in gene expression 
of the CaMKII isoforms occur in aged hippocampi. Similarly, the results of the relative 
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α-CaMKII western blot did not exhibit diminished expression of α-CaMKII in aged 
hippocampi. Also, the results of the CaMKIIα aggregation western blot did not exhibit 
that aggregation of α-CaMKII causes the decline in CaMKII activity in aged hippocampi.  
 
FUTURE STUDIES 
 
The impact of our findings lies in the illumination of the mechanisms causing 
CaMKII activity to decline in the aged wild-type mouse hippocampus. In the future, 
researchers should seek to build upon the link between decreased phosphorylated 
CaMKII expression and decreased CaMKII activity. Likewise, researchers should 
formulate strategies that increase CaMKII phosphorylation in order to alleviate learning 
and memory problems in the aging brain. In terms of building upon the methods used in 
this study, it would be beneficial to increase the number of animal subjects and to widen 
the range of subject ages at time of euthanasia. Because of the fact that our CaMKII 
inhibitor western blot was unsuccessful, this experiment should be repeated. Also, the 
expression of the other CaMKII isoforms in advanced age should be evaluated. Lastly, 
the effects of aging on other kinase proteins should be evaluated. 
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Supplemental Figure 1: complete images of a western blot used to quantify relative α-
CaMKII expression in young and aged wild-type mouse supernatant hippocampal tissue 
samples. Expression of α-CaMKII (50 kDa) and GAPDH (40 kDa) were quantified then 
used to determine relative α-CaMKII expression. In the first blot image, the blot was 
incubated with an α-CaMKII primary antibody. In the second blot image, the blot was 
incubated with a GAPDH primary antibody. Levels of relative alpha CaMKII expression 
were normalized to a value of one. The ordering of samples of each image from left to 
right is young-aged-young-aged etc. 
 
50 kDa 
40 kDa 
Supplemental Figure 1 
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Supplemental Figure 2: A complete image of a western blot used to quantify the 
expression of total CaMKII (CaMKIIα) aggregation in both young and aged pellet and 
supernatant hippocampal tissue samples. The ordering of samples in the image from left 
to right is young-aged-young-aged etc. 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 3: complete images of western blots used to quantify the relative 
expression of phospho-CaMKII in both young and aged supernatant hippocampal tissue 
samples. The expression of p-CaMKII was normalized to α-CaMKII. In the first blot 
image, the blot was incubated with an α-CaMKII primary antibody. In the second blot 
image, the blot was incubated with a P-CaMKII primary antibody. The ordering of 
samples of each image from left to right is young-aged-young-aged etc. 
50 kDa 
50 kDa 
Supplemental Figure 2 
Supplemental Figure 3 
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Supplemental Figure 4: A complete image of a western blot gel used to quantify the 
expression of CaMKII inhibitor (CaMK-Nβ) (6.5 kDa) in both young and aged supernatant 
hippocampal tissue samples. The ordering of samples in the image from left to right is 
young-aged-young-aged etc.  
Supplemental Figure 4 
6.5 kDa 
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